Oxford Global’s 13th Annual Proteins & Antibodies Congress will be attended by over 450 visionary leaders to network about the latest developments & participate in presentations from the areas of engineering, bioanalysis, biotherapeutics and bispecifics.
New for 2020 is the introduction of the kick-off sessions, providing an interactive experience for delegates through roundtable & panel discussions.
Key Speakers Include:
- Tristan Vaughan, Vice President, AstraZeneca
- John McCafferty, Chief Executive Officer, IONTAS Pharmaceuticals
- Surinder Kaur, Director, Genentech
- Kristin Brown, Director, GlaxoSmithKline
VIEW AGENDA: https://bit.ly/35Z0Rqw
Part of the Biologics Series, it is co-located with the 2nd Annual Bispecifics In Discovery & Development Congress and 7th Annual Peptides & Oligonucleotides Congress.
2020 Live Webinar:
“Discovery & Clinical Collaborations In Biotherapeutics”
Hosted by Robin Löving, Chief Scientific Officer, Salipro Biotech & Denise Steckel, Head, Clinical Collaborations Management, Genentech
Wednesday 29th January 2020 | 4PM GMT
REGISTER FOR FREE: https://bit.ly/2PNKDKY
Date: 27 - 29 April 2020
Location: London, UK